Testing for ESR1 Mutations in Breast Cancer
Kevin Kalinsky, MD, MS, and Erica L. Mayer, MD, MPH, discuss testing practices for ESR1 mutations in patients with breast cancer.
Source: onclive.com
Asco Recommendations News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Asco Recommendations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Asco Recommendations Today - Breaking & Trending Today
Overcoming Challenges in Biomarker Testing in Breast Cancer
Experts on breast cancer discuss challenges encountered in biomarker testing for patients with breast cancer.
Source: onclive.com
ASCO Recommends Trilaciclib in Extensive-Stage Small Cell Lung Cancer in Guideline Update
In their updated guidelines for patients with small cell lung cancer (SCLC), ASCO has recommended the CDK4/6 inhibitor trilaciclib as a myeloid supportive agent for patients with untreated or previously treated extensive-stage SCLC who are receiving chemotherapy or chemoimmunotherapy.
Source: onclive.com